SEARCH NEWS & VIEWS


The ‘Startup’ Lab: A Profile of Keary Engle
German and US Partners Join Forces in Stem Cell Research to Accelerate Development of New Therapies
Protect Against Taking the Phishing 'Bait'

NEWS & VIEWS HOME
PAST ISSUES
KUDOS
SCIENTIFIC CALENDAR
CA AUDITORIUM EVENTS
CONTACT




FOLLOW US
1
The ‘Startup’ Lab: A Profile of Keary Engle

TSRI alumnus and new faculty member Keary Engle is looking for faster, more environmentally sustainable ways to create important drug compounds.

German and US Partners Join Forces in Stem Cell Research to Accelerate Development of New Therapies

The research, which the Loring lab will conduct with colleagues at two German institutes, will focus on stem cell quality.

Protect Against Taking the Phishing 'Bait'

Vigilance is a first defense.

  • New Metabolomic Platform Reveals Fundamental Flaw in Common Lab Technology
  • Team Identifies Potential Target for Individualized Treatment of Autism Spectrum Disorder
  • Researchers Identify Promising Drug Candidate to Treat Chronic Itch that Avoids Side Effects
  • Scientists Identify a Key Morphine Regulator that May Reduce Risk of Pain-Killer Abuse and Addiction
  • Scripps Research Institute Names Peter Schultz as CEO, Steve Kay as President
  • TSRI and UC San Diego Launch New Consortium to Create ‘Virtual Cell’
  • Institute Receives $5.65 Million Gift from San Diego Philanthropist Helen Dorris
  • Institute Receives $12.5 Million Challenge Gift
  • Study by TSRI and Janssen Makes Major Advance Toward More Effective, Long-Lasting Flu Vaccine
  • Scientists Show How Aging Cripples the Immune System, Suggesting Benefits of Antioxidants
  • Team Finds a Better Way to Engineer Therapeutic Proteins into Antibodies
  • International Team Discovers the Ancient Origins of Deadly Lassa Virus
  • Team Makes Strides in Therapy Preventing Addiction Relapse by Erasing Drug-Associated Memories
  • Technology Meets Teamwork: Andrew Ward Unlocks Viruses’ Secrets
  • Team Finds New Antibody Weapons against Marburg Virus